Cargando…

Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA)

BACKGROUND: Reduction of cyclin-dependent kinase inhibitor 2A (CDKN2A) (p16 and p14) expression through DNA methylation has been reported in prostate cancer (PCa). This meta-analysis was conducted to assess the difference of p16 and p14 methylation between PCa and different histological types of non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Zipei, Wei, Lijuan, Zhu, Weizhi, Yao, Xuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	7300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895353/ https://www.ncbi.nlm.nih.gov/pubmed/29561434 http://dx.doi.org/10.1097/MD.0000000000010182

Ejemplares similares

CDKN2B Methylation Correlates with Survival in AML Patients
por: Kamali Dolatabadi, Esmat, et al.
Publicado: (2017)

Effect of magnesium sulfate on renal colic pain: A PRISMA-compliant meta-analysis
por: Chen, Liang-Fu, et al.
Publicado: (2020)

Relationship between premature ejaculation and depression: A PRISMA-compliant systematic review and meta-analysis
por: Xia, Yue, et al.
Publicado: (2016)

PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis
por: Zhang, Yu-ming, et al.
Publicado: (2017)

Kidney stones may increase the risk of coronary heart disease and stroke: A PRISMA-Compliant meta-analysis
por: Peng, Jian-Ping, et al.
Publicado: (2017)

Clinical efficacy of percutaneous nephrolithotomy versus retrograde intrarenal surgery for pediatric kidney urolithiasis: A PRISMA-compliant article
por: Lu, Pei, et al.
Publicado: (2017)

Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis
por: Fan, Yang, et al.
Publicado: (2015)

Self-Fluid Management in Prevention of Kidney Stones: A PRISMA-Compliant Systematic Review and Dose–Response Meta-Analysis of Observational Studies
por: Xu, Chang, et al.
Publicado: (2015)

Fruits and Vegetables Intake and Risk of Bladder Cancer: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies
por: Xu, Chang, et al.
Publicado: (2015)

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)

Surveillance, CDKN2A and survival of familial melanoma
por: van Doorn, Remco
Publicado: (2023)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis
por: Ma, Zhifang, et al.
Publicado: (2020)

Prognostic value of lymphocyte-to-monocyte ratio previously determined to surgery in patients with non-metastatic renal cell carcinoma: A systematic review and a prisma-compliant meta-analysis
por: Garcia-Rojo, Dario, et al.
Publicado: (2021)

Adding radiotherapy to androgen deprivation therapy in men with node-positive prostate cancer after radical prostatectomy: A meta-analysis
por: Guo, Lijuan, et al.
Publicado: (2020)

Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL: A meta-analysis
por: Huang, Yan, et al.
Publicado: (2018)

Perinatal DNA Methylation at CDKN2A Is Associated With Offspring Bone Mass: Findings From the Southampton Women's Survey
por: Curtis, Elizabeth M, et al.
Publicado: (2017)

Hallermann-Streiff syndrome with uncommon ocular features, ultrasound biomicroscopy and optical coherence tomography findings: A case report
por: Shen, Wei, et al.
Publicado: (2019)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis
por: Chang, Xueliang, et al.
Publicado: (2023)

CDKN2A methylation in esophageal cancer: a meta-analysis
por: Zhou, Chongchang, et al.
Publicado: (2017)

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Prostate tuberculosis mimicking prostate cancer: Case report and literature review
por: Li, Yu, et al.
Publicado: (2023)

The application of IL-10 and TNF-α in expressed prostatic secretions and prostatic exosomal protein in urine in the diagnosis of patients with chronic prostatitis
por: Yin, Lianli, et al.
Publicado: (2019)

Ezh2 Regulates Activation-Induced CD8(+) T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
por: Chen, Guobing, et al.
Publicado: (2018)

Molecular Genetics and Functional Analysis Implicate CDKN2BAS1-CDKN2B Involvement in POAG Pathogenesis
por: Rathi, Sonika, et al.
Publicado: (2020)

Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors
por: Balan, Daniel, et al.
Publicado: (2018)

The first case of bipolar transurethral resection of the prostate for giant prostatic hyperplasia: A case report
por: Cui, Deheng, et al.
Publicado: (2022)

Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022)

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications
por: Fang, Cheng, et al.
Publicado: (2017)

Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy
por: Flammia, Simone, et al.
Publicado: (2020)

Bladder cancer survival in patients with NOD2 or CDKN2A variants
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies
por: Dai, Xiaoyu, et al.
Publicado: (2016)

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2016)

Effect of prostate volume on the peripheral nerve block anesthesia in the prostate biopsy: A strobe-compliant study
por: Luan, Yang, et al.
Publicado: (2016)

Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
por: Vavallo, Antonio, et al.
Publicado: (2014)

Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL?
por: Park, Jee Soo, et al.
Publicado: (2019)

Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men
por: Han, Zihua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_63klqs3f7rncn6dk72q34tvtkn